Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Viral Immunology
|
November 9, 2017
Lessons from the Meningitis Vaccine Project
F Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Lancet (London, England)
|
June 6, 2003
Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries
Luis Jódar, F Marc LaForce, Costante Ceccarini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa
Jean-Marie Okwo-Bele, F Marc LaForce, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
The Evolution of the Meningitis Vaccine Project
Kathleen Tiffay, Luis Jodar, Marie-Paule Kieny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
MenAfriVac as an Antitetanus Vaccine
Ray Borrow, Yuxiao Tang, Ahmadu Yakubu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India
Prasad S Kulkarni, Muriel Socquet, Suresh S Jadhav, et al.
The Journal of Infectious Diseases
|
November 1, 2019
Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines
Mark R Alderson, F Marc LaForce, Ajoke Sobanjo-Ter Meulen, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
July 4, 2019
Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study
S M Niaz Arifin, Christoph Zimmer, Caroline Trotter, et al.
Plos Medicine
|
January 25, 2018
The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study
Reza Yaesoubi, Caroline Trotter, Caroline Colijn, et al.
Vaccine
|
December 10, 2008
Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa
Che-Hung Lee, Wen-Chun Kuo, Suresh Beri, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Viral Immunology
|
November 9, 2017
Lessons from the Meningitis Vaccine Project
F Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, et al.
Lancet (London, England)
|
June 6, 2003
Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries
Luis Jódar, F Marc LaForce, Costante Ceccarini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa
Jean-Marie Okwo-Bele, F Marc LaForce, Ray Borrow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
The Evolution of the Meningitis Vaccine Project
Kathleen Tiffay, Luis Jodar, Marie-Paule Kieny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
MenAfriVac as an Antitetanus Vaccine
Ray Borrow, Yuxiao Tang, Ahmadu Yakubu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India
Prasad S Kulkarni, Muriel Socquet, Suresh S Jadhav, et al.
The Journal of Infectious Diseases
|
November 1, 2019
Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines
Mark R Alderson, F Marc LaForce, Ajoke Sobanjo-Ter Meulen, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
July 4, 2019
Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study
S M Niaz Arifin, Christoph Zimmer, Caroline Trotter, et al.
Plos Medicine
|
January 25, 2018
The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study
Reza Yaesoubi, Caroline Trotter, Caroline Colijn, et al.
Vaccine
|
December 10, 2008
Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa
Che-Hung Lee, Wen-Chun Kuo, Suresh Beri, et al.
Page
of 5